Shorter Urethra Linked to Incontinence After BPH Laser Surgery | Medscape

For men considering a procedure to relieve urinary difficulties caused by an enlarged prostate, a new study suggests a potential way to assess their risk of urinary incontinence afterward. Researchers have found that men with a shorter membranous urethra – a section of the tube carrying urine from the bladder – appear more likely to experience incontinence following a laser enucleation of the prostate, a common surgical treatment known as HoLEP.

Understanding HoLEP and Incontinence

Benign prostatic hyperplasia (BPH), or an enlarged prostate, is a common condition affecting many men as they age. It can cause difficulty urinating, frequent urination and other bothersome symptoms. Holmium laser enucleation of the prostate (HoLEP) is a minimally invasive surgical procedure used to treat BPH. As explained by Johns Hopkins Medicine, the procedure uses a laser to remove the obstructing tissue from the prostate, relieving bladder obstruction. Learn more about HoLEP here.

Urinary incontinence, the involuntary leakage of urine, is a potential side effect of any prostate surgery. While generally temporary, it can be a concerning issue for patients. This new research, published in Medscape Medical News, focuses on identifying factors that might predict which men are at higher risk of developing this complication after HoLEP.

The Study and Its Findings

The study, as reported by Medscape, centers on the length of the membranous urethra. The membranous urethra is a short segment of the urethra that passes through the pelvic floor muscles. Researchers discovered a correlation between a shorter membranous urethra and an increased likelihood of urinary incontinence after HoLEP.

The findings stem from a retrospective review of data from a large, multi-center study involving over 5,000 patients who underwent HoLEP for BPH between January 2020 and January 2022, across 12 centers. Details of the study, including the methodology and participating centers, can be found in the Asian Journal of Andrology. The study compared outcomes for patients undergoing different techniques of laser prostate removal – en-bloc versus lobe-based approaches – but the finding regarding membranous urethra length emerged as a significant factor related to incontinence risk.

What Does This Mean for Patients?

It’s important to emphasize that this study identifies a correlation, not necessarily a direct causation. A shorter membranous urethra doesn’t automatically mean a man will experience incontinence after HoLEP. However, it suggests that men with this anatomical characteristic may be at a higher risk.

Currently, there isn’t a standard measurement of the membranous urethra routinely performed before HoLEP. However, this research suggests that incorporating such a measurement into pre-operative assessments could help surgeons better counsel patients about their individual risk profiles. It could also potentially inform surgical techniques, allowing surgeons to tailor their approach to minimize the risk of incontinence in those identified as higher risk.

The Importance of Context: Risk and Prevalence

Understanding the overall risk of incontinence after HoLEP is crucial. While the exact rates vary depending on the study and surgical technique, incontinence is generally considered a temporary issue for most men. The study referenced doesn’t provide specific incontinence rates, but other research indicates that the majority of men regain continence within a few months of surgery.

It’s also important to distinguish between different types of incontinence. Stress incontinence – leakage during activities like coughing or sneezing – is the most common type following prostate surgery. Urge incontinence – a sudden, strong urge to urinate – can also occur. The study doesn’t specify which type of incontinence was most prevalent in the higher-risk group with shorter membranous urethras.

What Comes Next: Refining Risk Assessment and Surgical Techniques

This research is a step towards more personalized care for men undergoing HoLEP. Further studies are needed to validate these findings and determine the optimal way to incorporate membranous urethra length into pre-operative risk assessment. Researchers will likely investigate whether specific surgical techniques can mitigate the risk of incontinence in men with shorter urethras.

The findings also highlight the importance of comprehensive pre-operative counseling. Men considering HoLEP should have a thorough discussion with their surgeon about the potential risks and benefits of the procedure, as well as their individual anatomical factors.

Ongoing surveillance and data collection will be essential to refine our understanding of incontinence risk after HoLEP. This includes tracking outcomes across different surgical centers and analyzing data from larger patient populations. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) supports research into BPH and related conditions, and their findings may contribute to improved treatment strategies in the future. Explore NIDDK’s research initiatives here.

the goal is to provide men with the most effective and safe treatment options for BPH, while minimizing the risk of bothersome side effects like urinary incontinence.